Justice Department investigators are probing a controversial arrangement under which kidney-care companies support charitable efforts to help patients pay health-insurance premiums, according to disclosures from major dialysis providers.
Shares of Anthera Pharmaceuticals Inc (NASDAQ: ANTH), a nano-cap bio-pharmaceutical company that focuses on developing and commercializing products to treat serious diseases, soared higher by more than 30 percent on Wednesday.
Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.